Results 61 to 70 of about 1,881 (168)

Influence of therapy chronic heart failure of functional class III on regulatory adaptive status

Кубанский научный медицинский вестник, 2014
100 patients with CHF FC III against the background of ischemic heart disease (IHD) and/or stage III hypertensive disease (HD). All them administered of complex therapy (Quinapril, Torasemide, Spironolactone).
E. S. Rokotyanskaya
doaj  

THE PRESCRIBING TRENDS OF ACE-INHIBITORS AFTER MYOCARDIAL INFARCTION IN TERTIARY CARE HOSPITALS OF HAZARA REGION

International Journal of Pharmacy & Integrated Health Sciences
Background: There is good evidence that angiotensin-converting enzyme (ACE) inhibitors are beneficial after myocardial infarction (MI). However, it is not known how widely this evidence is used in practice or whether all eligible patients receive this ...
Fiaz Alam, Ghazala Batool, Sidra Noureen, Muhammad Saad Khan, Mahnoor, Jamil ur Rehman, Iqra Zaman   +6 more
doaj   +1 more source

Overview of the clinical development of quinapril

Clinical Cardiology, 2009
Quinapril hydrochloride is the newest member of a family of angiotensin-converting enzyme (ACE) inhibitors. On completion of laboratory and animal studies, a clinical program was initiated to evaluate the antihypertensive and other properties of the drug in human subjects.
openaire   +2 more sources

Tendencia de la tensión arterial en mujeres con hipertensión arterial esencial-estadio II tratadas con un inhibidor de la enzima convertidora de angiotensina

Revista de la Facultad de Medicina, 1995
Objetivo: Valorar el comportamiento de la tensión arterial en un grupo de mujeres con hipertensión arterial esencial- estadio II tratadas con guinapril, un inhibidor de la enzima convertidora de angiotensina. Métodos: se realizó un estudio epidemiológico
Mario E. Garcés Ferrer, Luis A. López P., Esperanza Holguín   +2 more
doaj  

REGULATORY ADAPTIVE STATUS IN EVALUATION OF EFFECTIVENESS OF MEDICATION THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE OF FUNCTIONAL CLASS III

Кубанский научный медицинский вестник, 2014
100 patients with CHF FC III against the background of ischemic heart disease (IHD) and/or stage III hypertensive disease (HD) who received complex therapy (quinapril, torasemide, spironolactone) took part in the research.
E. S. Rokotyanskaya
doaj  

A validated stability-indicating LC method for simultaneous determination of quinapril and hydrochlorothiazide in pharmaceutical samples

Open Chemistry, 2014
Diego Marta, Mennickent Sigrid, Muñoz Juan, Sanhueza Fernanda, Godoy Ricardo   +4 more
doaj   +1 more source

Adolescent type 1 Diabetes cardio-renal Intervention Trial (AdDIT)

BMC Pediatrics, 2009
Background The prognosis for young people diagnosed with diabetes during childhood remains poor and this is mainly related to the long-term risk of developing vascular complications.
doaj   +1 more source

Efecto de telmisartan sobre marcadores del remodelado óseo en pacientes hipertensos Telmisartan effect's on remodelling bone markers in hypertensive patients

Nutrición Hospitalaria, 2012
Introducción: El telmisartan es un ARA II con unas características propias que nos permite obtener unos beneficios adicionales. Además de bloquear el receptor I de la angiotensina II, va actuar a través de receptores nucleares claves como el receptor ...
J. L. Pérez-Castrillón, D. de Luis, L. Inglada, J. M. Olmos Martínez, F. Pinacho, R. Conde, M. González-Sagrado, A. Dueñas-Laita   +7 more
doaj  

SMPD1-mediated sphingolipid metabolism dysregulation in predicting and preventing in-stent restenosis of coronary heart disease patients. [PDF]

J Pharm Anal
Meng W, Sha Y, Zhong-Ga CR, Pan H, Zhai X, Zhen P, Tong HHY, Lao EPL, Zhang H, Yang W, Cui S, Song X, Li K.   +12 more
europepmc   +1 more source

Are Angiotensin-Converting Enzyme Inhibitors Effective in the Treatment of Hypertension in Black Patients? [PDF]

CJC Open
Nkunu V, Campbell L, Tsuyuki RT, Bello AK, Ringrose J.   +4 more
europepmc   +1 more source